Hyperion Defi (HYPD) Cost of Revenue (2021 - 2025)
Hyperion Defi (HYPD) posted quarterly Cost of Revenue of $303242.0 for Q4 2025, down 90.22% year-over-year from $3.1 million in Q4 2024, and up 631654.17% quarter-over-quarter from $48.0 in Q1 2025.
Hyperion Defi (HYPD) Cost of Revenue (2021 - 2025) Analysis & Trends
Hyperion Defi (HYPD) has reported Cost of Revenue for 4 consecutive years, with $303242.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cost of Revenue fell 90.22% year-over-year to $303242.0; the TTM figure through Mar 2026 stood at $303242.0 (down 91.86% YoY), while the FY2025 annual figure was $303290.0, down 92.28% from the prior year.
- Cost of Revenue improved to $303242.0 in Q4 2025 per HYPD's latest filing, from $48.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $3.1 million in Q4 2024 and bottomed at $48.0 in Q1 2025.
- Historically, Cost of Revenue has averaged $584652.3 across 4 years, with a median of $253134.5 in 2024.
- Annual changes were most pronounced in 2024 — Cost of Revenue jumped 119688.26% — and 2025, when it plunged 99.98%.
- Hyperion Defi's Cost of Revenue stood at $800000.0 in 2021, then plunged by 99.68% to $2589.0 in 2023, then surged by 119688.26% to $3.1 million in 2024, then slumped by 90.22% to $303242.0 in 2025.
- Business Quant data shows HYPD's Cost of Revenue at $303242.0 in Q4 2025, $48.0 in Q1 2025, and $3.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 298.26 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 387.98 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.21 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 303,242.00 |
| Dec 31, 2025 | 303,242.00 |
| Mar 31, 2025 | 48.00 |
| Mar 31, 2025 | 48.00 |
| Dec 31, 2024 | 3.10 Mn |
| Dec 31, 2024 | 3.10 Mn |
| Sep 30, 2024 | 132,522.00 |
| Sep 30, 2024 | 132,522.00 |
| Jun 30, 2024 | 490,361.00 |
| Jun 30, 2024 | 490,361.00 |
| Mar 31, 2024 | 203,027.00 |
| Mar 31, 2024 | 203,027.00 |
| Dec 31, 2023 | 2,589.00 |
| Dec 31, 2023 | 2,589.00 |
| Sep 30, 2023 | 13,416.00 |
| Sep 30, 2023 | 13,416.00 |
| Jun 30, 2021 | 800,000.00 |
| Jun 30, 2021 | 800,000.00 |
| Mar 31, 2021 | 800,000.00 |
| Mar 31, 2021 | 800,000.00 |